Nellore Healthcare And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.17 Cr
as on 02-01-2025
- Revenue -20.51%
(FY 2021)
- Profit -5.54%
(FY 2021)
- Ebitda 36.25%
(FY 2021)
- Net Worth 46.06%
(FY 2021)
- Total Assets 18.53%
(FY 2021)
About Nellore Healthcare And Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.17 Cr.
Palchuri Reddy and Sneha Palchuri serve as directors at the Company.
- CIN/LLPIN
U85100AP2013PTC088204
- Company No.
088204
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2013
- Date of AGM
29 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nellore Healthcare And Research Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sneha Palchuri  | Director | 23-Sep-2021 | Current |
| Palchuri Reddy | Director | 05-Jun-2013 | Current |
Financial Performance of Nellore Healthcare And Research Institute.
Nellore Healthcare And Research Institute Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.51% decrease. The company also saw a slight decrease in profitability, with a 5.54% decrease in profit. The company's net worth Soared by an impressive increase of 46.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nellore Healthcare And Research Institute?
In 2021, Nellore Healthcare And Research Institute had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹21.68 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.19 Cr
- Syndicate Bank : 0.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2023 | Hdfc Bank Limited | ₹2.88 M | Open |
| 01 Feb 2021 | Hdfc Bank Limited | ₹9.00 M | Open |
| 01 Aug 2013 | Syndicate Bank | ₹9.80 M | Open |
How Many Employees Work at Nellore Healthcare And Research Institute?
Unlock and access historical data on people associated with Nellore Healthcare And Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nellore Healthcare And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nellore Healthcare And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
